Nouscom new Science Translational Medicine publication highlighted on Cancer Discovery #ResearchWatch

Nouscom new Science Translational Medicine publication is highlighted on Cancer Discovery #ResearchWatch, describing a novel mechanism of action driven by viral vector-based vaccine platform encoding tumor neoantigens overcoming anti-PD1 resistance and improving immunotherapy efficacy:
https://aacrjournals.org/cancerdiscovery/article-abstract/doi/10.1158/2159-8290.CD-RW2022-152/708761/Adenoviral-Based-Cancer-Vaccines-Promote-Anti-PD-1?redirectedFrom=fulltext

Read the full paper here: https://www.science.org/doi/10.1126/scitranslmed.abo7604